| Collaborations |
|
Seattle Genetics, Inc.
Seeking to jointly discover and develop antibody-based therapies for cancer.
|
|
Aventis Pharmaceuticals, Inc.
Aventis is investigating the use of Cathepsin S inhibitors in a number of therapeutic areas related to inflammation and autoimmune disease.
|
|
Maxim Pharmaceuticals, Inc.
Collaboration to identify and develop novel small-molecule compounds that induce apoptosis, potential new therapies for certain cancers.
|
|
Abbott Laboratories
Broad program to discover, develop and commercialize therapies for the treatment of cancer, including therapeutic antibodies and small molecules.
|
|
Merck & Co., Inc.
Genome databases, Alzheimer's disease, Diagnostics
|